Table 2 Comparison between the studied patients with and without liver affliction.
|  | Women without liver affliction (n = 46) | Women with liver affliction (n = 31) | P value |
|---|---|---|---|
Age, years | 27(23–33) | 29(24–34) | 0.468 |
DM | 0 | 0 | Â |
HTN | 9(19.7%) | 3(9.7%) | 0.371 |
CKD | 5(10.7%) | 0 | 0.077 |
Gestational age, weeks | 31(22–35) | 33(28–38) | 0.046 |
Gravidity | 3(2–4) | 2(1–3) | 0.228 |
Parity | 2(1–2) | 1(1–2) | 0.364 |
SBP | 120(110–150) | 130(77.5-172.5) | 0.875 |
DBP | 80(60–90) | 80(47.5–100) | 0.883 |
WBCs, 109/L | 11(7.45-14) | 14.7(10.75–19.63) | 0.009 |
Blood hemoglobin, g/dL | 8.80(7.55–10.15) | 8.40(6.80-10.93) | 0.665 |
Platelets, 109/L | 166(107-248.5) | 100(49.75–147) | 0.002 |
Serum creatinine, mg/dL | 2.25(1.48–5.23) | 2.10(1.60–4.50) | 0.905 |
Quantitative proteinuria, mg/day | 1900(150–4000) | 425(150–1875) | 0.139 |
Serum albumin, g/dL | 2.86 ± 0.54 | 2.79 ± 0.56 | 0.612 |
Total bilirubin, mg/dL | 0.80(0.65–0.90) | 1.70(0.80-6) | 0.002 |
ALT, U/L | 25.5(21-35.25) | 143(65–418) | < 0.001 |
AST, U/L | 23(21–36) | 103(59.5–279) | < 0.001 |
INR | 1.02(1-1.15) | 1.30(1.01–1.99) | 0.001 |
Serum uric acid, mg/dL | 7.48(5.20–10.40) | 7.80(5.40–9.40) | 0.985 |
Dialysis requirement | 15(32.6%) | 11(35.5%) | 0.811 |
Maternal mortality | 4(8.7%) | 10(32.3%) | 0.009 |
Renal recovery | 31(67.4%) | 17(54.8%) | 0.156 |
Fetal mortality | 17(37%) | 13(41.9%) | 0.779 |
